Elsevier

Early Human Development

Volume 46, Issue 3, 21 November 1996, Pages 239-258
Early Human Development

Retinopathy of prematurity: guidelines for screening and treatment

https://doi.org/10.1016/S0378-3782(96)01747-1Get rights and content

Abstract

Following the report that severe retinopathy of prematurity (ROP) can be treated effectively, a working party of the Royal College of Ophthalmologists and the British Association of Perinatal Medicine was convened in 1990 to draw up guidelines for screening [1]. These have been revised by a reconvened working party (Appendix D) and the document expanded to include other relevant issues such as the practicalities of treatment, counselling and end-stage retinopathy.

  • • Screening is recommended for all babies at risk of severe ROP, i.e. those of birth weight ≤ 1500 g and or ≤ 31 weeks gestational age.

The aim of screening is to identify severe ROP (stage 3) which may require treatment, or, in a baby due to be discharged to home or to another hospital, any ROP which has the potential to become severe.

  • • The first examination should be between 6 and 7 weeks postnatal age, and subsequent examinations continued until vascularisation has progressed into zone 3 when the risk of stage 3 ROP has passed.

  • • As the window of time available for treatment is very short, examinations should be undertaken every 2 weeks.

  • • Treatment is currently undertaken when threshold stage has been reached. Threshold ROP is defined as:

    • • Stage 3 ROP:

    • • involving five or more contiguous or eight or more cumulative clock hours

    • • in the presence of congestion of the posterior pole vessels - ‘plus’ disease.

  • • Treatment can be by cryotherapy or laser in the neonatal unit.

  • • Parents have a right to know what may befall their baby, and it is important to provide balanced information, and this should be given to parents of babies:

    • • at risk of developing any ROP

    • • who are close to or have severe disease or requiring treatment

    • • blinded by ROP.

  • • Despite meticulous clinical care, babies are occasionally blinded by ROP That is not the end of the road and there is still work for the clinician to do:

    • • counsel on the role of vitrectomy

    • • manage the disorganised anterior segment

    • • initiate and actively participate in the care of the visually impaired child.

The screening and management should be undertaken or supervised by senior ophthalmologists with a specific interest in this condition. It is recommended that one or two consultants in each area should gain expertise and supervise training.

Referencing here is not exhaustive with preference being given to recent reviews. With certain exceptions citations are at the commencement of each section rather than at specific issues.

References (53)

  • College News: ROP screening duty

    Q. Bull. Coll. Ophthalmol.

    (1990)
  • Multicenter trial of cryotherapy for retinopathy of prematurity results

    Arch. Ophthalmol.

    (1988)
  • Multicenter trial of cryotherapy for retinopathy of prematurity: three-month outcome

    Arch. Ophthalmol.

    (1990)
  • Multicenter trial of cryotherapy for retinopathy of prematurity: one-year outcome

    Arch. Ophthalmol.

    (1990)
  • Multicenter trial of cryotherapy for retinopathy of prematurity. 3.5-year outcome structure and function

    Arch. Ophthalmol.

    (1993)
  • D.R. Brown et al.

    Screening criteria for the detection of retinopathy of prematurity in patients in a neonatal intensive care unit

    J. Pediatr. Ophthalmol. Strabismus

    (1987)
  • K.E.W.R. Tan et al.

    Timely incidence of examination for acute retinopathy of prematurity (ROP) and its consequence for the screening strategy

    Am. J. Perinatol.

    (1989)
  • A.W. Biglan et al.

    Update on retinopathy of prematurity

    Int. Ophthalmol. Clin.

    (1989)
  • D.B. Schaffer

    Update on retinopathy of prematurity: the examination guidelines

    Semin. Ophthalmol.

    (1990)
  • H.C. Fledelius et al.

    Retinopathy of prematurity. Where to set the screening limits? Recommendations based on two Danish surveys

    Acta Paediatr. Scand.

    (1990)
  • B.A. Darlow et al.

    Retinopathy of prematurity: screening and optimal use of the ophthalmologist's time

    Aust. New Zealand J. Ophthalmol.

    (1990)
  • J.F. Acheson et al.

    Surveillance for retinopathy of prematurity in practice: experience from one neonatal intensive care unit

    Eye

    (1991)
  • A.R. Fielder

    Cryotherapy of retinopathy of prematurity

  • A.R. Fielder et al.

    Screening for retinopathy of prematurity

    Arch. Dis. Child.

    (1992)
  • P.T. Urrea et al.

    Retinopathy of prematurity: an ophthalmologist's perspective

  • Cited by (129)

    • A national telemedicine network for retinopathy of prematurity screening

      2018, Journal of AAPOS
      Citation Excerpt :

      Screening began 4 weeks after delivery or when the premature infant reached a gestational age of 31 weeks. Subsequent examinations were scheduled according to ROP screening guidelines.3,12,13 Examinations continued until both eyes reached full retinal vascularization or zone III immature vascularization at gestational age of ≥37 weeks or until ROP treatment was required.

    • The Challenge of Screening for Retinopathy of Prematurity

      2013, Clinics in Perinatology
      Citation Excerpt :

      A recent multicentered, randomized clinical trial (ETROP)28 studying earlier laser treatment of severe ROP emphasized the need for more frequent examinations to result in accurate and timely diagnosis of treatable disease. However, this has added significantly to the overall burden of ROP evaluations.27,29 An audit in the United Kingdom in 1997/1998 reported that 55 ROP examinations by an ophthalmologist occurred for every infant who required laser treatment.30

    • Retinopathy of Prematurity

      2022, Albert and Jakobiec's Principles and Practice of Ophthalmology: Fourth Edition
    • Retinopathy of prematurity

      2021, Perinatology: Evidence-Based Best Practices in Perinatal Medicine
    View all citing articles on Scopus
    View full text